Skip to content

Evaluation of Near Visual Acuity With ODYSIGHT, a Smartphone Based Medical App in Comparison to a Standardized Method

Evaluation of Near Visual Acuity With ODYSIGHT, a Smartphone Based Medical Application in Comparison to a Standardized Method

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03457441
Acronym
TIL-001
Enrollment
120
Registered
2018-03-07
Start date
2018-03-20
Completion date
2018-07-24
Last updated
2018-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Near Vision

Brief summary

This study evaluates the level of agreement between visual parameters tested using OdySight, a mobile application, and standards in office methods.

Interventions

OTHERStandards vision tests

Subjects vision : near visual acuity, contrast sensitivity and scotoma and metamorphopsia detection will be assessed by gold-standard tests and with the OdySight medical application

DEVICEOdySight medical application assessment

Subjects vision : near visual acuity, contrast sensitivity and scotoma and metamorphopsia detection will be assessed by gold-standard tests and with the OdySight medical application

Sponsors

Tilak Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years * Able to correctly distinguish the body laterality (left and right) * Able to recognize alphabet letters and read French * Affiliated to or beneficiary of the French health care system * Signed/written informed consent * Subject presenting a level of visual acuity of one of his eyes that fits to one of the pre-set cohort (visual acuity between +1.0 and +0.7 logMAR, between +0.6 and +0.3 logMAR or between +0.2 and 0.0 logMAR); the two eyes can be included in two different cohorts.

Exclusion criteria

* Any pathology that is considered by the investigator as capable of affecting the quality of the main evaluation criteria. * Pregnant and breastfeeding women. * Subject not considered by the investigator or designee to correctly use OdySight modules after the training session

Design outcomes

Primary

MeasureTime frameDescription
Near visual acuity assessment with OdySight versus with near visual acuity chart1 day ( During evaluation visit)To assess the equivalence between a smartphone based evaluation of near visual acuity with ODYSIGHT (NVA module) and a standardized method (Sloan ETDRS near vision letter chart).

Secondary

MeasureTime frameDescription
Near visual acuity assessment with OdySight versus with ETDRS chart1 day ( During evaluation visit)To assess the relation between the ETDRS visual acuity at a 4-meter distance and near visual acuity evaluated with ODYSIGHT (NVA module)

Other

MeasureTime frameDescription
Contrast sensitivity assessment with OdySight versus with Pelli-Robson1 day ( During evaluation visit)To compare the smartphone based evaluation of the contrast sensitivity with ODYSIGHT (contrast sensitivity module) and a standardized method (Pelli-Robson chart)
Scotoma/metamorphopsia detection with OdySight versus with standard Amsler grid1 day ( During evaluation visit)To compare the smartphone based evaluation of the Amsler Grid with ODYSIGHT (Amsler grid module) and standardized methods (paper Amsler Grid)
Global functional disorders assessment with Odysight versus with OCT1 day ( During evaluation visit)To compare functional disorder(s) detected or measured by ODYSIGHT application with anatomical data (OCT: Optical coherence tomography)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026